[go: up one dir, main page]

IN2009DN07390A - - Google Patents

Download PDF

Info

Publication number
IN2009DN07390A
IN2009DN07390A IN7390DEN2009A IN2009DN07390A IN 2009DN07390 A IN2009DN07390 A IN 2009DN07390A IN 7390DEN2009 A IN7390DEN2009 A IN 7390DEN2009A IN 2009DN07390 A IN2009DN07390 A IN 2009DN07390A
Authority
IN
India
Prior art keywords
human
tissues
derived therefrom
cells derived
relates
Prior art date
Application number
Inventor
Charles Roland Wolf
Nico Scheer
Original Assignee
Iti Scotland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iti Scotland Ltd filed Critical Iti Scotland Ltd
Publication of IN2009DN07390A publication Critical patent/IN2009DN07390A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/80—Cytochromes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to transgenic non-human animals, tissues or cells derived therefrom and methods of producing them. The transgenic non-human animals or tissues or cells derived therefrom provide a system capable of expressing human proteins responsible for drug metabolism in place of the homologous endogenous non-human animal proteins and for the controlled expression of human genes introduced into the animal so that the expression of the human genes is regulated in a manner more closely analogous to that seen in vivo in humans. One aspect of the invention relates to the use of a human DNA sequence comprising at least part of introns 6 and/or 7 of the human PXR gene.
IN7390DEN2009 2007-06-04 2008-06-04 IN2009DN07390A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/757,972 US7759541B2 (en) 2004-12-13 2007-06-04 Transgenic animals for assessing drug metabolism and toxicity
PCT/GB2008/001897 WO2008149080A1 (en) 2007-06-04 2008-06-04 Transgenic animals for assessing drug metabolism and toxicity

Publications (1)

Publication Number Publication Date
IN2009DN07390A true IN2009DN07390A (en) 2015-07-24

Family

ID=39698732

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7390DEN2009 IN2009DN07390A (en) 2007-06-04 2008-06-04

Country Status (8)

Country Link
US (3) US7759541B2 (en)
EP (1) EP2173160A1 (en)
JP (1) JP2010528644A (en)
AU (1) AU2008259618A1 (en)
CA (1) CA2688438A1 (en)
IL (1) IL202127A0 (en)
IN (1) IN2009DN07390A (en)
WO (1) WO2008149080A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
AU2008322038B2 (en) * 2007-11-14 2012-02-23 National University Corporation Tottori University Mammalian artificial chromosome vector comprising human cytochrome P450 gene (cluster) and non-human mammalian animal retaining the same
ES3010323T3 (en) 2009-10-06 2025-04-02 Regeneron Pharma Genetically modified mice and engraftment
WO2011160573A1 (en) * 2010-06-21 2011-12-29 中国科学院上海生命科学研究院 Method for producing rifamycin sv with high activity and high purity
US20120023599A1 (en) * 2010-07-23 2012-01-26 Sigma-Aldrich Co. Genome editing of cytochrome p450 in animals
KR102714361B1 (en) 2011-02-15 2024-10-11 리제너론 파마슈티칼스 인코포레이티드 Humanized m-csf mice
FR2979453B1 (en) * 2011-08-26 2016-01-08 Olea Medical SYSTEM AND METHOD FOR ESTIMATING A QUANTITY OF INTEREST IN AN ARTERY / FABRIC / VEIN DYNAMIC SYSTEM
PL2663575T3 (en) * 2011-10-28 2015-03-31 Regeneron Pharma Humanized il-6 and il-6 receptor
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
KR102473555B1 (en) 2012-09-07 2022-12-05 예일 유니버시티 Genetically modified non-human animals and methods of use thereof
IL311744B2 (en) * 2012-11-05 2025-10-01 Regeneron Pharma Genetically modified non-human animals and methods of use thereof
US20140273031A1 (en) * 2013-03-15 2014-09-18 The Cleveland Clinic Foundation In-vitro method for monoclonal antibody production
EP3138397B1 (en) 2013-10-15 2018-12-26 Regeneron Pharmaceuticals, Inc. Humanized il-15 animals
MX356809B (en) * 2013-11-19 2018-06-13 Regeneron Pharma Non-human animals having a humanized b-cell activating factor gene.
EP3071025B1 (en) * 2013-11-19 2018-10-10 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
US9665718B2 (en) 2014-03-14 2017-05-30 International Business Machines Corporation Correlating a task with commands to perform a change ticket in an IT system
KR20250096864A (en) 2014-05-19 2025-06-27 리제너론 파마슈티칼스 인코포레이티드 Genetically modified non-human animals expressing human epo
CN107896479B (en) 2015-04-13 2021-07-13 再生元制药公司 Humanized SIRPα-IL15 knock-in mice and methods of use
EP3474662A1 (en) 2016-06-27 2019-05-01 Baylor College of Medicine Human liver chimeric non-human animal with deficient p450 oxidoreductase and methods of using same
CN109182292B (en) * 2018-09-25 2022-02-08 安徽农业大学 Strawberry glutathione transferase FaGST gene and expression protein and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6476000A (en) 1999-08-13 2001-03-13 Kirin Beer Kabushiki Kaisha Mouse having human cytochrome p450 transferred therein
EP1088900A1 (en) 1999-09-10 2001-04-04 Epidauros Biotechnologie AG Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications
AU2002213660A1 (en) 2000-11-01 2002-05-15 The University Of Sydney Transgenic animals for analysing CYP3A4 cytochrome P450 gene regulation
AUPR446701A0 (en) 2001-04-18 2001-05-17 Gene Stream Pty Ltd Transgenic mammals for pharmacological and toxicological studies
JP2003304896A (en) 2002-04-15 2003-10-28 Yasushi Yamazoe Method for measuring human CYP3A inducibility
GB0216203D0 (en) 2002-07-12 2002-08-21 Imp Cancer Res Tech Mondulation of cytochrome P450 reductase activity
EP1539946A4 (en) * 2002-09-09 2006-03-15 California Inst Of Techn METHODS AND COMPOSITIONS FOR THE PRODUCTION OF HUMANIZED MOUSE
ES2391099T3 (en) * 2004-12-13 2012-11-21 Iti Scotland Limited Transgenic animals to assess the metabolism and toxicity of a drug
US7759541B2 (en) 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity

Also Published As

Publication number Publication date
US20100257620A1 (en) 2010-10-07
US20080148416A1 (en) 2008-06-19
US8212105B2 (en) 2012-07-03
IL202127A0 (en) 2010-06-16
US7759541B2 (en) 2010-07-20
CA2688438A1 (en) 2008-12-11
US8624079B2 (en) 2014-01-07
JP2010528644A (en) 2010-08-26
EP2173160A1 (en) 2010-04-14
AU2008259618A1 (en) 2008-12-11
US20100235928A1 (en) 2010-09-16
WO2008149080A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
IN2009DN07390A (en)
EP2172549A3 (en) RNAi expression constructs
WO2008155133A3 (en) Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof
WO2009007855A3 (en) Reversible sirna-based silencing of mutant and endogenous wild-type huntingtin gene and its application for the treatment of huntington's disease
MX2007007602A (en) Glp-1 agonists, compositions, methods and uses.
EP2302034A3 (en) Improved methods of reprogramming animal somatic cells
WO2008054466A3 (en) Delivery of biologically active materials using core-shell tecto (dendritic polymers)
WO2008011446A3 (en) Human glp-1 mimetibodies, compositions, methods and uses
WO2007118245A3 (en) Methods and compositions related to adenoassociated virus-phage particles
WO2007035213A3 (en) Transgenic ungulates expressing ctla4-ig and uses thereof
WO2006001021A3 (en) Chimeric avian-based screening system containing mammalian grafts
WO2008153743A3 (en) Compositions and methods for cancer gene discovery
WO2006047603A3 (en) Ungulates with genetically modified immune systems
WO2004108904A3 (en) Porcine cmp-n-acetylneuraminic acid hydroxylase gene
MX2012000918A (en) System and method of feeding beneficial insects.
BRPI0510206A (en) phenotype identification method, single cell, agent identification methods, agents, therapeutic agents, therapeutic agent evaluation method, pharmaceutical composition, treatment methods, dysfunction prevention or amelioration and modulation methods
WO2006064197A3 (en) Transgenic animals for assessing drug metabolism and toxicity
IL274740B2 (en) Non-human animals containing a human TRKB locus
WO2005047469A3 (en) PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
NZ598769A (en) Transgenic chickens
Garrott et al. The Madison Headwaters elk herd: transitioning from bottom–up regulation to top–down limitation
WO2005111204A3 (en) Porcine forssman synthetase cdna and polypeptide
WO2006074012A3 (en) Facilitated cellular reconstitution of organs and tissues
HK1140912A (en) Transgenic animals for assessing drug metabolism and toxicity
DE60002603D1 (en) PHOSPHORUS-CONTAINING DENDRIMERS AS TRANSFECTION AGENTS